Medical Gazette. With the arrival of biosimilars in the Spanish market, new opportunities and challenges open up. Julio Maset, corporate scientific director of Infarco-Cinfa, details both visions.
Medical Gazette. With the arrival of biosimilars in the Spanish market, new opportunities and challenges open up. Julio Maset, corporate scientific director of Infarco-Cinfa, details both visions.